Western Standard Hedges With Biotech TradeMark Melin
Eric Andersen and Robert Wallendorf, portfolio manager and director of research respectively at Western Standard Partners, have a portfolio objective in 2018. The Los Angeles-based long/short hedge fund, up 2.6% as of March, is beating the Russell 2000, which is down 0.1%, through stock selection and creating a “margin of safety,” borrowing a technique from legendary value investor Seth Klarman. In their March letter to investors reviewed by ValueWalk they explain their reasons for a short hedge.
“The partnership’s goal for the second quarter of . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible